narcolepsy
NARCOLEPSY

Narcolepsy is a chronic neurologic sleep disorder wherein the patient have excessive daytime sleepiness and rapid eye movement sleep is dysregulated.

It affects 1 in 1000 individuals, with prevalence of about 0.04% of general population.
The exact cause remains unclear.
Studies suggest a combination of genetic predisposition, abnormal neurotransmitter functioning and abnormal immune modulation.
Symptoms include excessive daytime sleepiness, cataplexy, sleep paralysis, sleep-related hallucinations, automatic behavior, fragmented nocturnal sleep and insomnia.

Narcolepsy Patient Education

Patient Education

Patient Education

  • Educate the patients regarding their condition & its implications at the time of diagnosis
  • Regular consultation between the patient & physician is essential to help patients modify their lifestyle & provide optimal management
  • Family support can also improve the course of the disease by helping the patients overcome challenges
  • Inform family members, friends, & co-workers of the signs of narcoleptic spells to help patients lessen possible injuries
  • Advise patients on their activities & jobs
    • Avoid potentially dangerous activities such as operating motor vehicles & machines when feeling sleepy
    • Avoid shift-work, driving, transportation-related jobs, or any work which requires continuous attention for long hours with breaks

Adequate & Regular Nocturnal Sleep

  • Patient should have adequate & regular nocturnal sleep to avoid exacerbating excessive daytime sleepiness
  • Comply with a strict sleep schedule of at least 7-8 hours of sleep at night with a consistent bedtime & time of morning awakening
Editor's Recommendations
Most Read Articles
23 Apr 2018
Long‐term treatment with perampanel in the adjunctive setting appears to provide improved seizure control without raising new safety/tolerability signals in patients with epilepsy, particularly those with secondarily generalized seizures at baseline, according to the results of an open-label extension of phase III trials.
Audrey Abella, 20 Mar 2020
The addition of highly purified cannabidiol (CBD) into an antiepileptic regimen led to reductions in convulsive seizure rates in children with Dravet syndrome (DS), the GWPCARE2* study has shown.
27 May 2020
High rather than low levels of neonatal 25(OH)D3 pose an increased risk of incident epilepsy in early childhood, a finding that may be attributed to chance, confounding, or late gestational vitamin D exposure, according to a study.
Jairia Dela Cruz, 29 Jan 2020
In the treatment of idiopathic generalized epilepsy, switching from valproate to other antiepileptic drugs due to potential childbearing issues may prove detrimental, heightening the risk of poor seizure control, as shown in a recent study.